Remdesivir may help treat Covid-19 but the predictable media hype misrepresents the science. The data has not been published nor peer reviewed. There is a study in the Lancet that does not demonstrate efficacy hence the need for further investigation to determine if this truly is a treatment option.

Dr. Barry Dworkin

Medical Mythbusting Commentary for April 30, 2020

[display_podcast]

Source:
Remdesivir: Drug has ‘clear-cut’ power to fight coronavirus

The COVID-19 research news rollercoaster is running again: STAT News + Gilead’s remdesivir

Reference:
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Related posts:

  1. PM Trudeau, your flouting of pandemic health policy rules demoralizes the country. Armchair “physicians”, stop flaunting cherry-picked preprint studies as “the” evidence HCQ works when there are just as many that refute it. That is why proper investigation and meta-analysis are required.
  2. Interesting approach using monoclonal antibodies to treat Covid-19 infections. However clinical trials must follow to confirm in vitro findings.
  3. What are some of the concerns about the new variant of SARS-CoV-2 with respect to transmission, number of fatalities, and its impact on children?
  4. Will the COVID antiviral medications be the Thor’s Hammer against SARS-CoV-2 and help mitigate the ravages of the pandemic? These are impressive drugs but there are logistical, social, geographical, and financial caveats to solve in the process.